StonvexLoading…
StonvexStonvexStonvexCore line items from BILL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.22B | $810.41M | $395.74M | $1.46B |
Operating Income | $-39.20M | $-38.79M | $-20.72M | $-80.60M |
Net Income | $7.24M | $-2.59M | $-2.96M | $23.80M |
EPS (Diluted) | $0.07 | $-0.05 | $-0.03 | $-0.07 |
Total Assets | $10.08B | $10.13B | $10.15B | $10.06B |
Total Liabilities | $6.28B | $6.32B | $6.27B | $6.15B |
Cash & Equivalents | $994.67M | $1.09B | $1.10B | $1.04B |
Free Cash Flow OCF − CapEx | $301.89M | $199.38M | $95.56M | $346.31M |
Shares Outstanding | 102.31M | 101.23M | 101.92M | 103.01M |